Search results
408 results found
What the UK Biobank data exposure should mean for the Health Data Research ServiceBlogPotential fallout from the recent UK Biobank data exposure - and similar cases - highlights that governance cannot be treated as an administrative add on.
Rethinking HbA1c: genetics, diversity and diabetes diagnosisBlogRethinking HbA1c: genetics, diversity and diabetes diagnosis
Policy priorities for implementing personalised prevention in EuropeBlogPolicy briefing outlining recommendations for EU and national governments to implement personalised prevention programmes.
What the BOADICEA breakthrough means for health policyBlogThe Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) model underlies CanRisk, the web interface used to assess women for high risk of familial breast cancer syndromes, and is an example of well validated polygenic scores
Redefining genomic testing: is it time to talk about ‘near-perfect’ sequencing?BlogTechnological advances are changing the way geneticists view genome sequencing, with advances opening new possibilities and continuing to push our understanding.
The European Health Data Space and the UK: where things stand nowBlogAs the European Union moves to operationalise the European Health Data Space (EHDS), a framework with the potential to transform cross-border health research, the pathway for participation by third countries such as the UK remains notably unclear.
Risk prediction tools in primary care: it’s not just about the modelBlogHow can we overcome the technical and structural barriers to the implementation of disease risk prediction tools?